Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 6613 

for transplant but prior to anastomosis 

of the first organ. The committee voted 

unanimously in favor of the change. 

Potential revision to the 2020 

Guideline: HHS has reviewed the 

ACBTSA recommendations and other 

available information and is considering 

the following revision to current 

recommendations in the 2020 

Guideline. 

Exempt solid organ transplant 

candidates who are ≤10 years of age at 

the time of transplant (and who have 

received postnatal infectious disease 

testing) from the recommendation for 

HIV, hepatitis B virus, and hepatitis C 

virus testing during the hospital 

admission for transplant but prior to 

anastomosis of the first organ. 

HHS is not considering changes to 

any other 2020 Guideline 

recommendations. We seek informed 

feedback regarding this proposed 

change to the recommendations in the 

2020 Guideline. 

Dated: January 25, 2022. 

James J. Berger, 

Designated Federal Officer, Advisory 

Committee on Blood and Tissue Safety and 

Availability, Office of Infectious Disease and 

HIV/AIDS Policy. 

Footnotes 

1. Jones JM, Kracalik I, Levi ME, et al. 

Assessing Solid Organ Donors and 

Monitoring Transplant Recipients 

for Human Immunodeficiency 

Virus, Hepatitis B Virus, and 

Hepatitis C Virus Infection—U.S. 

Public Health Service Guideline, 

2020. MMWR Recomm Rep 

2020;69(No. RR–4):1–16. DOI: 

http://dx.doi.org/10.15585/ 

mmwr.rr6904a1. 

2. OPTN Policy 15.2: Candidate PreTransplant Infectious Disease 

Reporting and Testing 

Requirements. Available: https://

optn.transplant.hrsa.gov/media/ 

eavh5bf3/optn-policies-effective-asof-dec-6-2021-e-signature.pdf. 

3. CDC. Guidelines for preventing 

transmission of human 

immunodeficiency virus through 

transplantation of human tissue and 

organs. Centers for Disease Control 

and Prevention. MMWR 

Recommendations and reports: 

Morbidity and mortality weekly 

report Recommendations and 

reports/Centers for Disease Control. 

1994;43(RR–8):1–17. 

4. CDC. Testing donors of organs, 

tissues, and semen for antibody to 

human T-lymphotropic virus type 

III/lymphadenopathy-associated 

virus. MMWR Morbidity and 

mortality weekly report. 

1985;34(20):294. 

5. Seem DL, Lee I, Umscheid CA, 

Kuehnert MJ. PHS guideline for 

reducing human immunodeficiency 

virus, hepatitis B virus, and 

hepatitis C virus transmission 

through organ transplantation. 

Public health reports (Washington, 

DC: 1974). 2013;128(4):247–343. 

6. Centers for Disease Control and 

Prevention. HIV Surveillance 

Report, 2019; vol.32. http://

www.cdc.gov/hiv/library/reports/ 

hiv-surveillance.html. Published 

May 2021. 

7. Centers for Disease Control and 

Prevention. 2019 Viral Hepatitis 

Surveillance Report. https://

www.cdc.gov/hepatitis/statistics/ 

SurveillanceRpts.htm. Published 

July 2021. 

8. FastStats—Immunization (cdc.gov): 

https://www.cdc.gov/nchs/fastats/ 

immunize.htm. 

9. Elam-Evans LD, Yankey D, Singleton 

JA, et al. National, Regional, State, 

and Selected Local Area 

Vaccination Coverage Among 

Adolescents Aged 13–17 Years— 

United States, 2019. MMWR Morb 

Mortal Wkly Rep 2020;69:1109– 

1116. DOI: http://dx.doi.org/ 

10.15585/mmwr.mm6933a1. 

[FR Doc. 2022–02389 Filed 2–3–22; 8:45 am] 

BILLING CODE 4150–28–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated Review 

Group; Aging Systems and Geriatrics Study 

Section. 

Date: March 3–4, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Inese Z. Beitins, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6152, 

MSC 7892, Bethesda, MD 20892, 301–435– 

1034, beitinsi@csr.nih.gov. 

Name of Committee: Healthcare Delivery 

and Methodologies Integrated Review Group; 

Organization and Delivery of Health Services 

Study Section. 

Date: March 3–4, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Catherine Hadeler 

Maulsby, MPH, Ph.D., Scientific Review 

Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, (301) 435–1266, 

maulsbych@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–20– 

117: Maximizing Investigators’ Research 

Award (MIRA) for Early Stage Investigators 

(R35—Clinical Trial Optional). 

Date: March 8–9, 2022. 

Time: 9:00 a.m. to 8:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Anita Szajek, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Bethesda, MD 20892, 301–827–6276, 

anita.szajek@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Drug Discovery Involving the 

Nervous System. 

Date: March 8–9, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Lai Yee Leung, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1011D, 

Bethesda, MD 20892, (301) 435–1042, 

leungl2@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Biomaterials, Delivery, and 

Nanotechnology. 

Date: March 10–11, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David Filpula, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6181, 


lotter on DSK11XQN23PROD with NOTICES1
6614 Federal Register / Vol. 87, No. 24 / Friday, February 4, 2022 / Notices 

MSC 7892, Bethesda, MD 20892, 301–435– 

2902, filpuladr@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Instrumentation, Environmental 

and Occupational Safety. 

Date: March 10–11, 2022. 

Time: 9:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Joonil Seog, SCD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Bethesda, MD 

20892, 301–402–9791, joonil.seog@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: SBIR/STTR Commercialization 

Readiness Pilot (CRP) Program. 

Date: March 10, 2022. 

Time: 9:00 a.m. to 7:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Allen Richon, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6184, 

MSC 7892, Bethesda, MD 20892, 301–379– 

9351, allen.richon@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Fellowship: 

Cancer Immunology and Immunotherapy. 

Date: March 10–11, 2022. 

Time: 9:30 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ola Mae Zack Howard, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7806, Bethesda, MD 20892, 301–451– 

4467, howardz@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Oncology. 

Date: March 10–11, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Reigh-Yi Lin, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Rm. 4152, 

MSC 7846, Bethesda, MD 20892, (301) 827– 

6009, lin.reigh-yi@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; RFA–RM– 

21–018: NIH Director’s Early Independence 

Awards. 

Date: March 10–11, 2022. 

Time: 10:00 a.m. to 8:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Suzanne Ryan, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1712, ryansj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Skeletal Biology and Tissue 

Engineering. 

Date: March 10, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Yi-Hsin Liu, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4214, 

MSC 7814, Bethesda, MD 20892, (301) 435– 

1781, liuyh@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflict: Cardiovascular Sciences. 

Date: March 10, 2022. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Richard D. Schneiderman, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4138, 

Bethesda, MD 20817, 301–402–3995, 

richard.schneiderman@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Gut 

Inflammation and Microbiome. 

Date: March 11, 2022. 

Time: 12:00 p.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ganesan Ramesh, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2182, 

MSC 7818, Bethesda, MD 20892, (301) 827– 

5467, ganesan.ramesh@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: January 31, 2022. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02347 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of General Medical 

Sciences; Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: NIGMS Initial Review 

Group Training and Workforce Development 

Study Section—B. 

Date: March 11, 2022. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Natcher Building, 45 Center Drive, Bethesda, 

MD 20892 (Video Meeting). 

Contact Person: Stephanie L. Constant, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, Division of Extramural 

Research Activities, National Institute of 

General Medical Sciences, National Institutes 

of Health, 45 Center Drive, Room 3AN12, 

Bethesda, MD 20892, 301–443–8784, 

constantsl@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.859, Biomedical Research and 

Research Training, National Institutes of 

Health, HHS) 

Dated January 31, 2022. 

Miguelina Perez, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–02329 Filed 2–3–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Human Genome Research 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 


lotter on DSK11XQN23PROD with NOTICES1